DARE TO LIVE; DARE TO THRIVE
Live / Applied — Final refusal mailed (as of 12 Jan 2026)
What this means for you
Not registered yet, but its 25 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99155794
- Mark type
- Stylized text
- Filed
- 25 Apr 2025
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the field of women's health; pharmaceutical preparations for treating dysmenorrhea, pelvic pain, sexual pain, and symptoms of endometriosis and menopause affecting sex; pharmaceutical preparations, namely, analgesic gels for vaginal use; pharmaceutical preparations, namely, selective estrogen receptor modulator suppositories for vaginal use; intravaginal drug delivery device for the continuous release of pharmaceutical preparations, sold filled with hormones; hormone replacement therapy preparations; hormones; vaginal preparations, namely, vaginal melatonin
Owner
- Daré Bioscience, Inc., San Diego, CA, US
Prosecution history
- 12 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Jan 2026 — FINAL REFUSAL E-MAILED
- 12 Jan 2026 — FINAL REFUSAL WRITTEN
- 18 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Sept 2025 — NON-FINAL ACTION E-MAILED
- 17 Sept 2025 — NON-FINAL ACTION WRITTEN
- 17 Sept 2025 — ASSIGNED TO EXAMINER
- 03 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Apr 2025 — NEW APPLICATION ENTERED